D ad
Company: Abbvie
Job title: asd
Seminars:
Investor Panel: Navigating Partnerships, & Investment Challenges in Psychosis Drug Development 3:00 pm
Explore the scientific, regulatory, and commercial uncertainties that make psychosis R&D a uniquely high-risk category, and how these risks shape both pharma and investor interest Discuss how innovative startups and emerging biotech companies can forge mutually beneficial relationships with pharma and venture investors What makes a small biotech compelling? Insights into what large pharma and…Read more
day: Day Two
Panel Discussion: Reframing Muscarinic Modulation: Lessons from Trials, Selectivity Challenges & the Placebo Puzzle 10:00 am
Explore real-world clinical trial insights, including implications of placebo response and operational variability on muscarinic agent outcomes. Discuss the evolving understanding of M1 vs. M4 receptor agonism and their roles in achieving therapeutic efficacy in schizophrenia.Read more
day: Day One
Chair’s Closing Remarks 4:00 pm
day: Day Two
Chair’s Opening Remarks 8:55 am
day: Day One
Chair’s Closing Remarks 6:00 pm
day: Day One